Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Une patiente et un médecin

Centre for Clinical Investigation Neurosciences

Last update: 15/10/2024 Reading time: 1min

Created in 1995, the Centre d’Investigation Clinique (CIC) Neurosciences is a clinical research platform dedicated to diseases of the nervous system. It is located in the heart of Paris Brain Institute.

What is the CIC Neurosciences?

What is the CIC Neurosciences?

The Centre d’Investigation Clinique (CIC) Neurosciences is a day hospital and clinic unit dedicated to clinical research on diseases of the nervous system.

The CIC Neurosciences has dedicated premises and staff trained in clinical research for the study of neurological and psychiatric diseases in optimum conditions of quality, ethics and safety. The main pathologies studied are: Parkinson’s disease, multiple sclerosis (MS), dementias, neurogenetics, neuropsychiatry, amyotrophic lateral sclerosis (ALS), peripheral neuropathies, epilepsy.
 

Since its creation in 2010, a major effort has been made to structure clinical research and it can now be said that Paris Brain Institute is a driving force for clinical research at the Pitié-Salpêtrière Hospital, one of the most renowned centres of neurology and psychiatry in the world.

Pr Catherine LUBETZKI Neurologist (AP-HP, Sorbonne University), Director of the Medical-University Department (DMU) of the Pitié-Salpétrière Hospital, Medical Director of Paris Brain Institute and leader of the team "remyelination in multiple sclerosis"
Le CIC Neurosciences
Le CIC Neurosciences

The CIC Neurosciences collaborates closely with the doctors of the Department of Medical-University (DMU) Neurosciences AP-HP Sorbonne University, the research teams of Paris Brain Institute, and the drug manufacturers for therapeutic trials. The aim of the studies carried out is to gain a better understanding of the pathologies affecting the nervous system and to offer patients access to innovative therapeutics.

The CIC Neurosciences Today

The CIC Neurosciences Today

Today, the CIC Neurosciences within Paris Brain Institute coordinates about 80 clinical trials initiated by public investigators (about 60%) and by industrialists (about 40%). Half of these trials are therapeutic, about 25% are pathophysiologic, and about 25% are clinically and biologically characterized cohorts.

Le Centre d’Investigation Clinique Neurosciences est situé au premier étage de l’Institut du Cerveau
Le Centre d’Investigation Clinique Neurosciences est situé au premier étage de l’Institut du Cerveau

Contact the CIC Neuroscientists

Contact the CIC Neuroscientists
 

To contact the Centre for Clinical Investigation (CIC) Neurosciences:

Click here

News that might interest you

Interneurones. Crédit : UCLA Broad Stem Cell Research Center.
Stimulating specific neurons in the striatum stops compulsive behaviour
What if we could resist compulsions? These irrational behaviours, particularly common in obsessive-compulsive disorder (OCD), are hard to suppress. At Paris Brain Institute, Éric Burguière's team shows that we can anticipate them and block them ...
09.10.2024 Research, science & health
Les nerfs moteurs présents dans la moelle épinière se projettent vers la périphérie, où ils entrent en contact avec les muscles, formant des connexions appelées jonctions neuromusculaires. Crédit : James N. Sleigh.
Ultrasound show unexpected effects on motor neuron disease
Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain ...
09.05.2024 Research, science & health
Un neurone
Rett syndrome: a new gene therapy on the way
Gene therapy could be our best chance of treating Rett syndrome, a neurological disorder that causes severe intellectual and motor impairments. At Paris Brain Institute, Françoise Piguet and her colleagues have looked closely at brain cholesterol ...
07.16.2024 Research, science & health
Lésions d’un patient à l’inclusion dans le protocole (M0) disparues après 2 ans de traitement à la Leriglitazone (M24)
The dual effect of leriglitazone in X-linked Adrenoleukodystrophy (X-ALD)
In 2023, the team led by Professor Fanny Mochel (AP-HP, Sorbonne University), a Paris brain Institute researcher, showed that daily dose of leriglitazone slow down the progression of myelopathy in patients with X-linked adrenoleukodystrophy, and ...
06.28.2024 Research, science & health
Une tête de statue de l'île de Pâques sur laquelle sont posées des éléctrodes
A multimodal approach to better predict recovery in patients with disorders of consciousness
When a patient is admitted to intensive care due to a disorder of consciousness—such as a coma—establishing their neurological prognosis is a crucial yet challenging task. To reduce the uncertainty that precedes the medical decision, a group of ...
05.30.2024 Research, science & health
Population de bactéries commensales (en rouge) dans un intestin grêle de souris. Crédit : University of Chicago
The composition of the gut microbiota could influence decision-making
The way we make decisions in a social context can be explained by psychological, social, and political factors. But what if other forces were at work? Hilke Plassmann and her colleagues from the Paris Brain Institute and the University of Bonn show ...
05.16.2024 Research, science & health
See all our news